Intelligence Platform
Patents
Browse 446 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8557245
Methods for treating bone cancer by administering a nerve growth factor antagonist antibod
granted patentUS 8507552
Triptolide prodrugs
granted patentUS 8470520
Decellularization and recellularization of organs and tissues
granted patentUS 8450471
TAL effector-mediated DNA modification
granted patentUS 8440431
TAL effector-mediated DNA modification
granted patentUS 8440432
Tal effector-mediated DNA modification
granted patentUS 8440205
Streptococcal C5A peptidase vaccine
granted patentUS 8415457
Modified vitamin K-dependent polypeptides
granted patentUS 8415458
Modified vitamin K-dependent polypeptides
granted patentUS 8409859
Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
granted patentUS 8399428
Nucleosides with antiviral and anticancer activity
granted patentUS 8394794
Therapeutic compounds
granted patentUS 8361768
Heat resistant bioactive composition
granted patentUS 8357656
Natriuretic peptide receptor-C agonists
granted patentUS 8343539
Compounds that bind Ξ±5Ξ²1 integrin and methods of use
granted patentUS 8309070
Use of umbilical cord blood stem cells to treat ischemic event
granted patentUS 8252280
MAPC generation of muscle
granted patentUS 8236925
Protein nanorings
granted patentUS 8227432
Transposon system and methods of use
granted patentUS 8222015
Heat resistant bioactive composition
granted patentUS 8207228
Calixarene-based peptide conformation mimetics, methods of use, and methods of making
granted patentUS 8197870
Depolymerization extraction of compounds from birch bark
granted patentUS 8168754
Modified vitamin K-dependent polypeptides
granted patentUS 8101382
Modified vitamin K-dependent polypeptides
granted